Photo for illustration (Source: NDO)
278 received the jabs from the university, while 276 others in Ben Luc district, the Mekong Delta province of Long An, were vaccinated by HCM City-based Pasteur Institute.
The information was released by Associate Prf., Dr. Chu Van Men, Director of the Military Medical University’s Centre for Clinical Trials and Bioequivalence.
After the injection, the volunteers exhibited symptoms such as light fever, injection site pain, muscle aches, joint pain and fatigue, which did not require medical intervention. They are now in stable conditions, reported VNA.
A preliminary report on testing results is scheduled to be issued this May.
The third phase of human trials is expected to cover 10,000 – 15,000 people in both Vietnam and other countries.
The first-stage trials of Nano Covax showed that the vaccinated volunteers have had antibodies against the UK variant (B117). Phase 2 focuses on seeking antibodies against the UK and South Africa variants, according to Men.
Navo Covax, developed by the Nanogen Pharmaceutical Biotechnology JSC, is the first COVID-19 vaccine of Vietnam to be tested in clinical trials.